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Aspartate transcarbamoylase (ATC), an essential enzyme for de novo pyrimidine biosynth-
esis, is uniquely regulated in plants by feedback inhibition of uridine 5-monophosphate
(UMP). Despite its importance in plant growth, the structure of this UMP-controlled ATC and
the regulatory mechanism remain unknown. Here, we report the crystal structures of Ara-
bidopsis ATC trimer free and bound to UMP, complexed to a transition-state analog or
bearing a mutation that turns the enzyme insensitive to UMP. We found that UMP binds and
blocks the ATC active site, directly competing with the binding of the substrates. We also
prove that UMP recognition relies on a loop exclusively conserved in plants that is also
responsible for the sequential firing of the active sites. In this work, we describe unique
regulatory and catalytic properties of plant ATCs that could be exploited to modulate de novo
pyrimidine synthesis and plant growth.
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Pyrimidine nucleotides are crucial to all living organisms ascomponents of nucleic acids as well as cofactors in thesynthesis of sugars, polysaccharides, glycoproteins, and
phospholipids1,2. However, much remains unknown in plants
about the unique organization, regulation, and localization of the
enzymes required for de novo biosynthesis of pyrimidines1, which
are potential targets for crop improvement and weed control.
This metabolic pathway starts in the chloroplast, where aspartate
transcarbamoylase (ATC) catalyzes the condensation of carba-
moyl aspartate from aspartate (Asp) and carbamoyl phosphate
(CP)1,3 (Fig. 1a). ATC can be anchored to the inner plastid
membrane4, which might facilitate the channeling of carbamoyl
aspartate to a cytosolic dihydroorotase (DHO) potentially asso-
ciated to the outer plastid membrane1. The dihydroorotate pro-
duced by DHO diffuses to the mitochondrial intermembrane
space and is oxidized to orotate by dihydroorotate dehydrogenase
(DHODH), a membrane flavoprotein coupled to the respiratory
chain3,5. Orotate returns to the cytosol and is transformed to
uridine 5-monophosphate (UMP), the precursor of all pyrimidine
nucleotides, in a two-step reaction catalyzed by UMP synthetase
(UMPS). Importantly, only in plants, UMP inhibits the activity of
ATC by a yet unknown mechanism, creating a feedback loop that
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controls the flux through the pathway6–9 (Fig. 1a). UMP also
inhibits carbamoyl phosphate synthetase (CPS), the chloroplast
enzyme producing CP for both the synthesis of pyrimidines and
arginine10, although this effect is counteracted by ornithine to
sustain the production of arginine11,12 (Fig. 1a). Thus, ATC is the
major regulated enzyme for de novo synthesis of UMP in
plants13, but yet the feedback mechanism that makes this enzyme
different from any other ATC remains uncharacterized.
In general, ATCs consist of a catalytic homotrimer with three
active sites in between the subunits that can be allosterically
regulated by association with other proteins. The Escherichia coli
ATC, for instance, is formed by association of two catalytic tri-
mers with three dimers of regulatory subunits14 responsible for
the binding of nucleotides that diminish (UTP and CTP) or
enhance (ATP) the activity15,16. Other prokaryotic ATCs lack
regulatory subunits and thus, are insensitive to nucleotides17,18.
In eukaryotes other than plants, ATC is fused together with CPS
into a single multienzymatic protein named CAD that also con-
tains an active DHO (animals) or an inactive DHO-like domain
(fungi)10,19–21. The ATC domain of CAD also forms homo-
trimers, favoring the assembly of the protein into large hexameric
particles22–24, and its activity is modulated by the binding of UTP
to an allosteric region within CPS25,26. In striking contrast, plant
ATCs consist of a UMP-inhibitable homotrimer with no asso-
ciated subunits, meaning that both the catalytic and regulatory
sites must reside within the same polypeptide chain27. However,
despite the wealth of biochemical and structural knowledge on
ATCs from prokaryotes, fungi, and animals, there is no structural
information of any plant ATC so far. Thus, the putative binding
site for UMP and the catalytic and regulatory mechanisms of
ATC in plants remain unknown.
Here we show that the development of Arabidopsis thaliana
(Arabidopsis) can be severely impaired or enhanced by the
expression level of ATC. To understand this fundamental activity,
we determined the crystal structure of Arabidopsis ATC free and
bound to UMP, in complex with a transition-state analog, with
CP or bearing a site-specific mutation that turns the enzyme
insensitive to UMP. The structural, mutagenesis, and biochemical
analyses reveal unique catalytic and regulatory properties of plant
ATCs, suggesting new strategies to control de novo pyrimidine
synthesis and plant growth.
Results
ATC is key for plant growth and efficient photosynthesis. To
explore the importance of ATC for plant growth we used artificial
microRNA (amiRNA) to knockdown ATC (At3g20330) in Arabi-
dopsis. Two selected lines, atc-1 and atc-2, exhibited 16% and 10%
residual ATC transcript and a 3-fold or 20-fold drop in protein levels
compared to wild-type (WT; Col-0) controls (Fig. 1b–d). Conversely,
we constitutively overexpressed ATC in two Arabidopsis lines, ATC-
Ox1 and ATC-Ox2, which showed 13- and 16-fold increase in ATC
transcript and a 2.9-fold increase in protein levels (Fig. 1b–d).
After 4 weeks on soil, atc-1 and atc-2 downregulated lines showed
a strong reduction of growth, with fresh weights of 19% (0.53 ±
0.09 g plant−1) and 6% (0.16 ± 0.03 g plant−1) of the Col-0 control
plants (2.73 ± 0.21 g plant−1) (Fig. 1b, e). In contrast, ATC-Ox1
and ATC-Ox2 showed increased growth with fresh weights of 119%
(3.26 ± 0.09 g plant−1) and 126% (3.45 ± 0.09 g plant−1) compared to
Col-0, respectively (Fig. 1b, e).
ATC downregulated lines also showed pale leaves, suggesting
lower chlorophyll levels, and presumably impaired photosynth-
esis, whereas ATC-Ox lines exhibited no phenotypic alterations
other than the bigger size (Fig. 1b). Because of the pale leaf
coloration, 4 week old atc plants were subjected to pulse-
amplitude-modulation (PAM) fluorometry, which measures
chlorophyll fluorescence as an indicator of the photosynthetic
capacity. The electron transport rate (ETR) of atc lines was less
than 20% of Col-0, whereas ATC-Ox lines showed no significant
differences (Fig. 1f). The pronounced ETR decrease was in line
with a reduction in the maximal photosynthetic efficiency (Fv/
Fm), with values of 0.53 ± 0.03 and 0.50 ± 0.02 for atc-1 and -2,
respectively, which are markedly lower than the 0.79 ± 0.01
measured in controls (Fig. 1g). Again, Fv/Fm values in ATC-
Ox lines were similar to Col-0.
These results, together with previous studies13,28, demonstrate
a regulatory role of pyrimidine de novo synthesis in plant growth
and a key function of ATC herein.
Crystal structure of Arabidopsis ATC bound to UMP. To
investigate this central enzymatic activity, we attempted to pro-
duce the ATC from Arabidopsis, a 390 amino acid (aa) precursor
protein with an N-terminal chloroplast transit peptide (Fig. 2a
and Supplementary Fig. 1). Having difficulties to express the full-
length protein in E. coli, we tested different N-terminal truncated
forms. One construct spanning aa 82–390 (named atATC) was
purified as a stable homotrimer (Fig. 2b), and matched in size
(excluding the 2.6 kDa fusion tag) the 36 kDa mature enzyme in
whole leaf extracts (Fig. 2c). atATC produced diffraction quality
crystals readily and the structure was determined at 1.7 Å reso-
lution (Supplementary Table 1 and Supplementary Fig. 2). The
structure of the atATC trimer resembles a three-bladed propeller
with a concave face holding three active sites in between subunits,
thus preserving the overall architecture of the transcarbamoylase
family29 (Fig. 2d). Each subunit folds into two subdomains of
similar size: an N-domain (aa 82–221 and 374–390) occupying
the center of the trimer and holding the binding site for CP, and a
C-domain (aa 222–373) bearing the Asp binding site (Fig. 2a, d
and Supplementary Figs. 1 and 3). The relative orientation of the
Fig. 1 ATC central activity in de novo pyrimidine synthesis and plant growth. a Scheme of de novo pyrimidine biosynthesis pathway (highlighted in cyan
with enzymatic activities in yellow background) and arginine synthesis (in orange) in plants. ATC, aspartate transcarbamoylase; DHO, dihydroorotase;
DHODH, dihydroorotate dehydrogenase; UMPS, UMP synthetase; CPS, carbamoyl phosphate synthetase; OTC, ornithine transcarbamoylase. Allosteric
inhibition by UMP and activation by ornithine are indicated by red and blue lines, respectively. b Arabidopsis Col-0 and ATC downregulated (atc-1 and -2)
or overexpressing lines (ATC-Ox1 and 2) grown for 4 weeks in a 14 h light and 10 h dark regime. c ATC transcript levels in knockdown and overexpressing
lines relative to Col-0 (n= 9). ATC transcript levels relative to actin: 9.5 × 10−3 (Col-0), 1.5 × 10−3 (atc-1), 0.93 × 10−4 (atc-2), 0.13 (ATC-Ox1), and 0.15
(and ATC-Ox2). p-values are 5.722 × 10−14 for atc-1, 5.93 × 10−15 for atc-2, 1.056 × 10−10 for ATC-Ox1, and 1.016 × 10−10 for ATC-Ox2. d Immunoblot with
anti-ATC antibody on whole leaf extracts; Coomassie Brilliant Blue (CBB) stained SDS-PAGE was used as loading control. The ATC protein levels relative to
Col-0 quantified from n-different experiments are: atc-1, 0.34 ± 0.17 (n= 5); atc-2, 0.05 ± 0.024 (n= 5); ATC-Ox1, 2.9 ± 0.44 (n= 4); and ATC-Ox2, 2.5 ±
0.87 (n= 4). e Fresh weight quantification (n= 10). f Electron transport rate (ETR) determined by PAM in standard light curve setting (n= 12 for Col-0,
n= 8 for atc-1, n= 11 for atc-2, n= 12 for ATC-Ox1, n= 11 for ATC-Ox2). p-values are 2.879 × 10−18 for atc-1, 4.563 × 10−20 for atc-2, 3.692 × 10−5 for ATC-
Ox1, 1.142 × 10−6 for ATC-Ox2. g False color presentation of maximal photosynthesis yield monitored by PAM of lines shown in f. Error bars indicate
standard error of the mean. Asterisks depict significant changes between the different lines referring to Col-0 control according to one-way ANOVA
followed by Tukey’s multiple comparison test (*p < 0.05, **p < 0.01, ***p < 0.001).
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domains is similar to the open conformation observed in other
ATCs crystallized without ligands (Supplementary Fig. 3)23,24,30.
In addition, atATC has the CP-loop (aa 156–169) and Asp-loop
(aa 309–332) (Fig. 2a, d) that, as in other ATCs16,24, undergo
large conformational movements upon substrate binding (see
below).
Unexpectedly, additional electron density in each active site
indicated the presence of a molecule of UMP captured during
protein expression and kept throughout the purification and
crystallization process (Fig. 2d, e and Supplementary Fig. 2). The
nucleotide fills the active site, with the ribose in C3′ endo pucker
and the base in anti conformation (Fig. 2e). The phosphate binds
near the N-end of helix H2 and interacts with R136, T137, R187,
and H215 (at the N-domain), whereas the ribose 2′- and 3′-OH
bind to the side chain of R248 (C-domain). The 4-O atom of the
pyrimidine ring interacts with R310 (Asp-loop), and the 2-O and
3-NH bind through three waters to R310, R248, and V250 (C-
domain), whereas the C5 and C6 atoms make Van der Waals
contacts with the 349PLP351 loop (C-domain). In addition, the
CP-loop from the adjacent subunit interacts with the inhibitor
through Van der Waals contacts of residues A164 and A165 and
makes a H-bond between S162 and the phosphate (Fig. 2d, e).
Next, we freed the enzyme of UMP by a gel filtration procedure
(Supplementary Fig. 4) and determined the crystal structure of
the apo form at 3.1 Å resolution (Supplementary Table 1). The
structure turned to be similar to the UMP-inhibited conformation
except for aa 160–166 of the CP-loop that appear disordered in
the absence of the nucleotide (Supplementary Fig. 3).
atATC only binds one molecule of PALA per trimer. We
investigated the effect of PALA [N-(phosphonacetyl)-L-aspar-
tate], a potent ATC inhibitor with structural features of both
substrates that mimics the transition-state of the reaction31–33.
Seedling assays in the presence of 0.2 mM or 0.4 mM PALA
showed a decrease in fresh weight to 59% or 23%, respectively,
compared to untreated seedlings (3 times 10 seedlings were
weighted per treatment, n= 3). Root length in untreated seed-
lings was 2.68 ± 0.49 cm and was reduced to 36% at 0.2 mM
PALA (0.96 ± 0.22 cm) and to 8% at 0.4 mM PALA (0.21 ± 0.09
cm) (n= 30) (Fig. 3a). These results support the reduced growth
observed in atc downregulated lines (Fig. 1b–d) and agree with
previous PALA-inhibition studies32. Chlorosis was also apparent
in PALA-treated seedlings (Fig. 3a), further endorsing the effect
of reduced ATC levels on chloroplast functionality (Fig. 1f, g).
To gain further insight into the reaction mechanism, we
determined the structure of atATC in complex with the
transition-state analog at 1.6 Å resolution (Supplementary
Table 1). Surprisingly, the structure showed the atATC trimer
with PALA bound to only one of the subunits (Fig. 3b and
Supplementary Fig. 5). This subunit undergoes a 10° hinge
closure of the N- and C-domains and a 24° rigid body rotation of
the Asp-loop (Fig. 3c), emulating the movement needed to bring
CP and Asp in close contact to favor the reaction33,34. In contrast,
the other two subunits exhibit an open conformation, similar to
the apo or UMP-bound states, and have the active sites empty or
with two sulfate ions and one glycerol molecule from the
crystallization solution (Fig. 3b and Supplementary Fig. 5). Only
Fig. 2 Structure of Arabidopsis ATC bound to UMP. a Scheme of Arabidopsis ATC protein. b SEC-MALS analysis of purified atATC proves the formation
of a homotrimer. c Immunoblot of atATC and mature ATC from leaf extract. The experiment was performed three times with identical results. d Crystal
structure of atATC trimer with each subunit bound to one molecule of UMP (shown as yellow spheres). One subunit is shown on gray background. Protein
domains are colored as in (a). e Detail of the active site with UMP bound. Water molecules are shown as red spheres. Electrostatic interactions are
indicated as dashed lines.
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the CP-loop interacting with PALA is well-defined in the electron
density map, whereas the other CP-loops are flexibly disordered
(Fig. 3b).
The substoichiometric binding of PALA is remarkable, since
other ATCs bound three molecules of PALA per trimer24,34–37
and the interactions with the transition-state analog are virtually
identical to those observed in atATC (Fig. 3d and Supplementary
Fig. 6). The phosphonate group of PALA binds to the N-end of
helix H2 (N-domain) and the O atom of the carbamate moiety
interacts with T137, R187, and H215 (N-domain), whereas the N
atom binds to L350 (C-domain). Also, the α-carboxylate group
binds to R248 (C-domain) and the β-carboxylate binds to R310
and Q312 (Asp-loop). In addition, the CP-loop from the adjacent
subunit binds through S163 to the phosphonate moiety, and
places K166 at interacting distance of the phosphonate and the α-
and β-carboxylates (Fig. 3d).
Isothermal titration calorimetry (ITC) analyses confirmed that
PALA binds to only one site per trimer (KDPALA= 0.6 μM) and
somehow blocks the entrance of subsequent PALA molecules to
the other sites (Supplementary Table 2 and Supplementary
Fig. 7). This negative cooperativity effect is specific for PALA,
since the unoccupied subunits can still bind CP (KDCP=
140 μM) or UMP (KDUMP= 1.2 μM). We also observed negative
cooperativity, but to a lesser extent, in the titration with UMP,
since the nucleotide binds with a KDUMP= 0.2 μM to the first
site and reduces 10-fold the affinity of the other subunits. In
turn, CP showed equal affinity for the three active sites (KDCP=
77 μM).
These results strongly suggested that despite the overall
structural similarity with other ATCs, the atATC trimer uses a
mechanism of communication between active sites that allows
only one subunit to attain the closed catalytic conformation.
The CP-loop blocks the simultaneous closure of the subunits.
The explanation for the unusual binding of PALA to atATC was
Fig. 3 Inhibition of atATC by the transition-state analog PALA. a Inhibition of Arabidopsis seedlings after 7 days treatment with PALA. Images are typical
examples of 30 seedlings viewed per treatment. Scale bars indicate 0.5 cm. b Crystal structure of atATC trimer in complex with only one molecule of PALA
(shown as orange spheres). Dashed lines indicate flexibly disordered CP-loops. c Superposition of the three subunits in the PALA-bound trimer (colored as
in b) and in the UMP-bound subunit (in black). The arrows indicate the closure of the subunit upon PALA binding. The Asp-loop undergoes a 29° rotation
around an axis that has been represented and colored in red. d Detail of the binding of PALA to the active site. Water molecules are shown as red spheres.
Electrostatic interactions are indicated as dashed lines.
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likely at the CP-loop, as the most distinct element compared to
other non-plant ATCs (Fig. 2a and Supplementary Fig. 1). This
loop is flexible in the absence of ligands (Fig. 3b and Supple-
mentary Fig. 3) but adopts two distinct conformations whether
UMP or PALA are bound to the adjacent subunit (Figs. 2e and
3d). With UMP, the CP-loop folds in an extended “inhibited”
conformation, with A164, A165 and S162 interacting with the
nucleotide, S163 and K166 pointing outwards the active site, and
the side chain of F161 inserted in between subunits (Fig. 4a). In
turn, upon PALA binding, the CP-loop rearranges into two short
and nearly perpendicular 310 α-helices, placing S163 and K166 to
interact with the transition-state analog and moving A164, A165,
and S162 outwards the active site (Fig. 4b). In this “active” con-
formation, F161 flips 180° compared to the position with UMP,
and projects towards the trimer three-fold axis, where inter-
subunit distances are shortened by the interactions between
neighbor E156 residues (Fig. 4b). These tight contacts at the
center of the trimer are not observed in other ATCs bound to
PALA (Supplementary Fig. 6), suggesting that the position of
F161 may prevent other CP-loops from reaching a similar active
conformation.
Two additional atATC structures reinforced this hypothesis.
One structure, obtained from crystals with PALA and soaked in
CP (Supplementary Table 1), showed a trimer with one subunit
bound to PALA, a second subunit with CP, and a third subunit
with CP and with one glycerol and one sulfate ion filling the Asp
binding site (Fig. 4c and Supplementary Fig. 5). The second
structure, obtained by co-crystallization with CP, showed all three
subunits in the trimer bound to CP (Supplementary Table 1 and
Supplementary Fig. 5). In both structures, the three CP-loops in
the trimer fold in an active conformation but show poor electron
density compared to the rest of the protein. In fact, E160 and
F161 were traced in only one subunit, and modeling in similar
conformation in the other subunits caused steric clash and charge
repulsion (Fig. 4d).
Mutant F161A is not inhibited by UMP and binds three
PALAs. To further test the role of the CP-loop, we replaced
F161 with Ala (F161A). The mutation did not affect the solu-
bility nor the oligomeric state of the protein, but changed the
susceptibility of the enzyme to UMP, PALA, or to high
Fig. 4 The CP-loop folds in two different conformations for UMP or PALA binding. a, b Cartoon representation of the CP-loop (in magenta) over the
active site of the adjacent subunit (shown in surface representation) bound to UMP (a) or PALA (b). c Structure of atATC with one subunit bound to PALA,
a second one with CP, and the third having CP, glycerol, and one sulfate ion. A UMP molecule is shown in semitransparent gray to compare the position
relative to the ligands. d Detail view along the three-fold axis. The side chains of E160 and F161 are only seen in one subunit. Modeling of these two residues
in the other two subunits (shown in yellow semitransparent representation) causes steric clash and charge repulsion.
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concentrations of the substrates. Initial-rate plots of WT with
CP as variable ligand are hyperbolic in the absence of
UMP (Vmax= 93.23 ± 2.53 nmol min−1 μg−1, K0.5CP= 0.46 ±
0.04 mM, K0.5Asp= 0.94 ± 0.10 mM), but turn sigmoidal in the
presence of UMP, with a Hill-coefficient h= 2.2, indicating
positive cooperativity for CP binding (Fig. 5a and Supplemen-
tary Fig. 8), as previously described for wheat-germ ATC7.
In contrast, parallel assays with F161A proved that although
the catalytic activity is highly similar to the WT (Vmax= 115.0 ±
14.62 nmolmin−1 μg−1, K0.5CP= 0.62 ± 0.13mM, K0.5Asp=
3.20 ± 1.03mM), the enzyme is not inhibited by UMP and also
becomes more sensitive to the presence of PALA (Fig. 5a and
Supplementary Fig. 8). In addition, F161A showed decreased
activity at high substrate concentrations, with an inhibition
Fig. 5 Activity and crystal structure of atATC mutant F161A. a, b CP saturation curves of atATC WT (a) and F161A (b) in the absence and presence of
UMP or PALA. c Asp saturation curves for WT and F161A. Equations to fit the kinetic data are detailed in Methods. d, e Crystal structure of atATC-F161A
trimer complexed with UMP (d), and detail of the interactions of the CP-loop (e), showing a glycerol molecule replacing the missing F161 side chain.
f, g Crystal structure of F161A with PALA bound to the three active sites (f), and detail of the interactions around the molecular axis (g).
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constant (Ki) of 4.52mM, whereas this substrate inhibition effect
was not apparent in the WT (Fig. 5b, c and Supplementary Fig. 8).
ITC analysis failed to detect the binding of UMP to
F161A, supporting the loss of inhibition by the nucleotide
(Supplementary Table 2 and Supplementary Fig. 7). We also
found that F161A binds one molecule of PALA (KDPALA= 0.12
μM) with 5-fold higher affinity than WT, in agreement with the
enhanced inhibition, and also shows ~100-fold higher affinity for
CP (KDCP= 0.7 μM) (Supplementary Table 2 and Supplementary
Fig. 7). It seems likely that removal of the F161 side chain
destabilizes the inhibited conformation of the CP-loop, reducing
the affinity for UMP, and thus, favoring the alternate CP- or
PALA-bound conformation (Fig. 4a, b).
To better understand the effect of the mutation, we determined
the structure of F161A with UMP (Supplementary Table 1). In
apparent contradiction with the activity and ITC results, the
structure showed a molecule of UMP in the active site (Fig. 5d),
the CP-loop in the inhibited conformation, and the missing
F161 side chain being replaced by a glycerol molecule (Fig. 5e). It
is probable that the low-affinity binding of the nucleotide to the
active site of the mutated protein is favored by the higher
concentrations of nucleotide (5 mM) and protein (135 μM) used
in the crystallization condition compared to those in the ITC
experiments (70 μM UMP at most and 30-40 μM protein). We
also determined the structure of F161A crystallized with PALA
(Supplementary Table 1). Interestingly, the structure showed a
trimer bound to three molecules of PALA rather than one as in
the WT (Fig. 5f and Supplementary Fig. 5). Although ITC
indicated that PALA binds with high affinity to only one site per
trimer (Supplementary Table 2), the high concentrations of PALA
(2 mM) and protein in the crystallization condition must favor a
low-affinity binding to the other subunits. Importantly, the three
CP-loops fold in an active conformation, have well-defined
electron density, and show no steric clashes around the molecular
three-fold axis, since the bulky F161 side chain is missing and
E160 adopts alternate conformations (Fig. 5g).
Discussion
The pathway for de novo synthesis of UMP is evolutionary
conserved in all plants examined so far, and loss of function of
any of the enzymes involved is presumably lethal. However,
whereas downregulation of CPS, DHO, DHODH, or UMPS
(Fig. 1a) had little or no effect38,39, we showed that ATC down-
regulation strongly inhibits plant growth (Fig. 1b–e), as reported
in previous studies38,40, and causes a severe decrease in photo-
synthetic efficiency (Fig. 1f, g). Conversely, we also proved that
plant growth can be enhanced by ATC overexpression (Fig. 1b–f).
These results support the notion that ATC is not produced in
large excess in the cell38, and thus, those plants are especially
sensitive to ATC levels that exert highest control over pyrimidine
de novo synthesis. Indeed, the production of ATC is under
transcriptional regulation in response to tissue pyrimidine
availability38,40 and to growth signals mediated by the TOR
pathway41. However, transcription, synthesis and translocation of
ATC into the chloroplast are slow and energetically costly pro-
cesses that do not correct for rapid fluctuations needed to
maintain nucleotide homeostasis. For this, allosteric regulation by
UMP is the major mechanism controlling ATC activity in plants7,
but until now, we lack detailed information of how this feedback
loop occurs.
Now, the structures of atATC reveal the mechanism of inhi-
bition and explain the unsolved problem of why plant ATCs are
inhibited by UMP and not by UTP as in other organisms8,31
(Fig. 6). Rather than occupying an allosteric pocket, UMP binds
and blocks the active site (Figs. 2 and 6a), directly competing with
CP, the substrate binding in first place18,42. UMP binds to the
subunit in a wide-open conformation (Supplementary Fig. 3),
where the N- and C-domains cannot move further apart to
accommodate a di- or tri-phosphorylated nucleotide, thus
explaining why UDP or UTP are not inhibitors. On the other
hand, the pocket for the nitrogenous base is too small for the
double ring of a purine and highly selective for uracil, since the
methyl group of thymine would clash with the 349PLP351 loop,
whereas the cytidine amino group would distort the interaction
with R310 (Fig. 2e). Also, one would expect the binding of deoxy-
UMP to be weak based on the interaction between the ribose OH
groups and the side chain of R248, which mimic the recognition of
the Asp α-COOH group (Fig. 2e). However, these UMP-
interacting elements are common to other ATCs that do not
bind the nucleotide at the active site (Supplementary Fig. 1). Thus,
we propose that the capacity of plant ATCs to be selectively
inhibited by UMP relies on few small changes in the CP-loop
(Figs. 2e and 4a). Indeed, a single point mutation in the CP-loop,
F161A, is sufficient to turn atATC insensitive to UMP without
affecting the catalytic efficiency of the enzyme nor its inhibition by
PALA (Fig. 5, Supplementary Table 2, and Supplementary Fig. 8).
Since the sequence of the CP-loop appears invariant in all plant
ATCs known up to date (Supplementary Fig. 1), we propose that
the UMP-inhibition mechanism described here for Arabidopsis
ATC must be conserved across the plant kingdom. Thus, unlike
other bacterial or eukaryotic ATCs that rely on complex associa-
tions with regulatory proteins (Fig. 6b, c), the current structures
explain how plant ATCs have evolved to maintain a simple
organization with both catalytic and regulatory capacities within a
single protein chain (Fig. 6a). We hypothesize that this simplicity
is a convenient solution for the transcriptional regulation and
translocation of a single gene product into the chloroplast.
atATC has a surprising affinity for UMP, ∼400-fold higher
than for CP (Supplementary Table 2), which is explained by the
extensive contacts of the nucleotide with the CP and Asp binding
sites, similar to what PALA does. However, whereas binding of
PALA involves large conformational changes (Fig. 3c), UMP
binds to the more energetically favorable open state, and this
might explain the 3-fold higher affinity for UMP than for the
transition-state analog (Supplementary Table 2). It is uncertain
whether such affinity for the natural inhibitor is retained in vivo
or if it could be further increased by interaction with phospho-
lipids, as reported for wheat-germ ATC43. In any case, based on
these results, one would expect that ATC is constitutively
repressed under steady-state conditions if UMP in the plastid
reaches sub-millimolar concentrations similar to those estimated
at the cytoplasm38,39,44. However, the concentration of UMP in
the plastid is unknown and other features found in atATC suggest
that this important activity is fine-tuned by the balance of UMP
and CP contents in the cell. Indeed, we showed that the affinity
for UMP is modulated by the communication between subunits,
so that activity is diminished by high-affinity binding of the
inhibitor to one subunit, whereas complete inactivation requires a
10-fold increase in the UMP pool (Supplementary Table 2). On
the other hand, the response to UMP also varies with the con-
centration of CP, as shown by the change in the kinetic curves
from a hyperbola to a sigmoid (Fig. 5a). This behavior, which was
first described for wheat-germ ATC7, could be relevant for the
coordination of de novo pyrimidine and arginine synthesis, two
pathways that depend on CP availability11,12 (Fig. 1a). For
instance, when pyrimidine pools are low, the activity of UMP-free
ATC responds linearly with the concentration of CP (Fig. 5a,
hyperbola), competing with arginine synthesis to ensure the
production of nucleotides. Then, as UMP pool builds up, the
synthesis of pyrimidines is reduced by the end product inhibition
of ATC and CPS. However, upon CPS inhibition, ornithine
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Fig. 6 Different regulatory mechanisms in ATC. a Plant ATCs present a unique mechanism of regulation, where UMP binds and blocks the active site. The
CP-loop (represented in magenta) alternates between an UMP-bound inhibited conformation and an active conformation that ensures the sequential and
perhaps ordered firing of the active sites. b In bacteria, isolated ATC catalytic trimers are unregulated. The association of two catalytic trimers with three
dimers of regulatory subunits results in a holoenzyme that undergoes large conformational changes upon binding of UTP (inhibitor) or ATP (activator) to
allosteric sites in the regulatory subunits. c In eukaryotes other than plants, ATC is fused together with CPS and DHO into a single multienzymatic protein
named CAD that oligomerizes into hexamers where ATC trimers are proposed to occupy apical positions. The CPS and ATC activities are regulated by the
binding of UTP to a regulatory region within the CPS domain.
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accumulates and reverses the UMP inhibition on CPS, providing
CP for arginine synthesis. Meanwhile, ATC activity remains
negligible at low CP concentrations (Fig. 5a, sigmoid), but would
sharply increase if the CP pool allows feeding both metabolic
pathways.
atATC provides the example of an ATC trimer binding to a
single molecule of PALA (Fig. 3b and Supplementary Table 2).
Since PALA is a transition-state analog, these results strongly
indicate that the reaction in plant ATCs might occur in only one
subunit of the trimer at a time. Previously, we and others reported
that human and E. coli ATCs exhibit much lower affinities for
PALA by the third active site than the first two24,45, leading us to
suggest that despite being a trimer, ATCs might work more
efficiently if not all the subunits were catalytically active at a time,
perhaps avoiding intersubunit contacts that could slow down the
conformational movements needed during catalysis24 (Fig. 3c).
Indeed, we proposed that the obstruction between subunits forced
to work simultaneously could explain the inhibition at high
substrate concentrations, a well-characterized but poorly under-
stood phenomenon in ATCs46. Interestingly, we did not observe
substrate inhibition in atATC (Figs. 4d, 5a and Supplementary
Fig. 8), in agreement with the existence of a mechanism that
ensures the reaction of one subunit at a time. This mechanism
relies on the projection of F161 towards the three-fold axis, which
prevents the CP-loops from reaching simultaneously the active
conformation (Fig. 4b, d). Thus, F161 plays a dual role both
stabilizing the UMP inhibited conformation and synchronizing
the firing of the subunits. Indeed, mutation F161A does not only
turn the enzyme insensitive to UMP but also allows the binding
of three PALA molecules per trimer (Fig. 5e and Supplementary
Table 2), suggesting that the reaction can occur simultaneously in
the three active sites. However, the activity of F161A is not 3-fold
higher than the WT, likely due to the obstruction between sub-
units acting simultaneously. Indeed, we observed substrate inhi-
bition for F161A (Fig. 5b, c and Supplementary Fig. 8), although
less acute than other non-plant ATCs42,46.
Lastly, it is tempting to speculate that the sequential activation
of the subunits in plant ATCs could follow a specific order
(Fig. 6a). Certainly, the atATC structure with PALA and CP
provides a suggestive snapshot of each subunit at a different stage
of the reaction (Fig. 4c), and further studies should explore this
possibility.
The de novo pyrimidine synthesis pathway is a promising
target for biomedical and biotechnological intervention47,48. Our
analysis uncovers unique regulatory and catalytic mechanisms of
plant ATCs, offering the possibility to modulate this central
enzymatic activity and selectively inhibit or enhance plant growth
in a similar manner as observed by changing protein expression
(Fig. 1b). For instance, the design of new herbicides could be
based on UMP analogs with additional groups replacing the
observed water-mediated interactions (Fig. 2e), or on compounds
targeting the cavity at the three-fold axis and blocking the
sequential activation of the CP-loops. On the other hand, it
should be possible to enhance growth of transgenic crops
expressing UMP-insensitive and thus, constitutively active ATC.
The present results should guide in the design of highly efficient
and non-regulated ATC variants of biotechnological interest.
Methods
Plant growth. For DNA isolation, tissue collection and phenotypic inspection,
wild-type Col-0 and transgenic Arabidopsis thaliana (L.) Heynh. plants (ecotype
Columbia) were used throughout. Plants were grown in standardized soil
(ED73 Einheitserde, Humuswerke Patzer) soil under long day conditions
(120 μmol quanta m−2 s−1 in a 12 h light and 12 h dark regime, temperature 22 °C,
humidity 60%). Prior to germination, seeds were incubated for 24 h in the dark at
4 °C for imbibition. Alternatively, to assess the effect of PALA on growth, plants
were cultivated under short-day conditions in liquid culture according to a protocol
suitable for fresh weight determination and feeding of effector molecules49. For
growth experiments under sterile conditions, the seeds were surface sterilized in 5%
sodium hypochloride before adding them to the ½ MS liquid medium supple-
mented with 1% (w/v) sucrose with or without 0.1 mM, 0.2 mM, or 0.4 mM PALA.
The liquid cultures were maintained on a shaker at 100 rpm under the same light
and temperature conditions as soil-grown plants. Leaf extract of wild-type and
mutants was prepared by homogenizing leaf material in extraction buffer (50 mM
HEPES-KOH pH 7.2, 5 mM MgCl2, 2 mM phenylmethylsulfonyl fluoride (PMSF)
on ice. The homogenous extract was centrifuged at 20,000g for 10 min at 4 °C. The
supernatant was collected and stored on ice until use.
Construction of ATC knock down and overexpressor plants. ATC (pyrB;
At3g20330) knock down mutants were generated using an established protocol for
gene silencing by artificial microRNA (amiRNA)50. An amiRNA targeting pyrB
was designed using an online tool (http://wmd3.weigelworld.org). The sequence
TAATGACAGGTATATCGGCAG was used for generation of primers, and Gate-
way™ compatible sequences attP1 and attP2 were added to primers to engineer the
amiRNA fragment (Supplementary Table 3). Subsequently, the fragment was sub-
cloned via BP-clonase reaction into the Gateway™ entry vector pDONR/Zeo and via
LR-clonase reaction into the destination vector pK2GW7, which contains a 35S-
CaMV promoter. Several independent lines were obtained exhibiting 16-10% of
transcript and two were selected for further analysis. ATC overexpressor plants
were generated by cloning full-length ATC (for primers see Supplementary Table 3)
using Gateway technology into pUB-Dest under the control of the ubiquitin-10
promoter51.
Gene expression analyses. Leaf material of soil-grown plants was collected and
homogenized in liquid nitrogen prior to extraction of RNA with the Nucleospin
RNA Plant Kit (Macherey-Nagel, Düren, Germany) according to the manu-
facturer’s advice. RNA purity and concentration were quantified using a NanoDrop
spectrophotometer. Total RNA was transcribed into cDNA using the qScript
cDNA Synthesis Kit (Quantabio, USA). qPCR was performed using the quantabio
SYBR green quantification kit (Quantabio) on PFX96 system (BioRad, Hercules,
CA, USA) using specific primers (Supplementary Table 3), and At2g3760 (Actin)
was used as reference gene for transcript normalization.
Pulse-amplitude-modulation (PAM) fluorometry measurements. A MINI-
IMAGING-PAM fluorometer (Walz Instruments, Effeltrich, Germany) was used
for in vivo chlorophyll A light curve assays on intact, 6 week old dark-adapted
plants using standard settings52.
Protein production. Arabidopsis ATC sequence encoding aa 82–390 was PCR
amplified from cDNA using a pair of specific primers (Supplementary Table 3) and
transferred via NdeI-XhoI to a modified pET28a plasmid53. Mutant F161A was
made using the Quick-Change II-E site-directed mutagenesis kit (Stratagene) and a
pair of complementary primers (Supplementary Table 3). Transformed E. coli BLR
(DE3)-pLysS cells (Merck) were grown overnight at 37 °C in Terrific Broth (TB)
medium containing 25 μgml−1 kanamycin, 10 μgml−1 tetracycline, and 25 μgml−1
chloramphenicol to an optical density at 600 nm of 0.7–0.9. Protein expression
was induced with 0.5 mM isopropyl β-D-thiogalactopyranoside (IPTG) overnight at
37 °C. Cells were resuspended in buffer A (20mM Tris–HCl pH 8.0, 0.5M NaCl,
10 mM imidazole, 5% glycerol, 2 mM β-mercaptoethanol) and disrupted by soni-
cation. The clarified lysate was incubated with Ni-sepharose 6 fast flow beads (GE
Healthcare) equilibrated in buffer A. After washing with buffer A supplemented
with 40 mM imidazole, the protein was eluted in buffer A with 300mM imidazole.
The protein was further purified by size-exclusion chromatography on a Superdex
75 10/300 column (GE Healthcare, USA) equilibrated in buffer GF [20mM Tris pH
7.0, 0.1M NaCl, 2% glycerol, 0.2 mM Tris(2-carboxyethyl) phosphine (TCEP)]. The
protein was concentrated to 5mgml−1 in an Amicon ultracentrifugation device
(Millipore) with 10 kDa cutoff and directly used for further studies or supplemented
with 40% glycerol, flash-frozen in liquid nitrogen and stored at −80 °C. All pur-
ification steps were carried out at 4 °C and the purity of the sample was evaluated by
SDS-PAGE and Coomassie staining. Protein concentration was determined by
Bradford assay54 using bovine serum albumin (Sigma) for the standard curve.
To remove UMP from the purified protein, the sample was diluted to 1 mgml−1
and supplemented with 50mM CP and 100mM Asp, and filtered at room
temperature through three consecutive PD-10 desalting columns (GE Healthcare)
equilibrated in GF buffer containing 50mM CP and 100mM Asp. In between
columns, the 3.5 ml eluted sample was concentrated down to 2.5ml using an
Amicon ultracentrifugation device. In the last step, the sample was filtered through a
PD-10 in GF buffer without substrates.
SEC-MALS analysis. Molar mass was determined by size-exclusion chromato-
graphy coupled to multi-angle light scattering (SEC-MALS). In all, 400 μl of pur-
ified protein at 1.4 mgml−1 was fractionated on a Superdex 200 10/300 column
equilibrated in GF buffer using an AKTA purifier (GE Healthcare) at a flow rate of
0.5 ml min−1. The eluted sample was characterized by in-line measurement of
the refractive index and multi-angle light scattering using Optilab T-rEX and
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DAWN 8+ instruments, respectively (Wyatt). Data were analyzed with ASTRA
6 software (Wyatt) to obtain the molar mass and plotted with software GraphPad.
Immunoblotting. In all, 15 ng of recombinant ATC or 15 μg of a fresh protein
extract from Arabidopsis leaves separated in a 15% SDS-PAGE gel were transferred
onto a nitrocellulose membrane (Whatman, Germany) by wet blotting. The
membrane was blocked in phosphate-buffered saline plus 0.1% (v/v) Tween 20
(PBS-T) with 3% milk powder for 1 h at room temperature, followed by three
washes of 10 min in PBS-T. Then, the membrane was incubated with a rabbit
polyclonal antiserum raised against recombinant ATC (Eurogentec, Belgium) for
1 h, followed by three washes with PBS-T. Next, the membrane was incubated for
1 h with a horseradish peroxidase (HPR) conjugated anti-rabbit antibody (Pro-
mega, Walldorf, Germany) diluted in PBS-T with 3% milk powder. The result was
visualized by chemiluminescence using the ECL Prime Western blotting reagent
(GE Healthcare) and a Fusion Solo S6 (Vilber-Lourmat) imager.
Crystallization and structure determination. Initial crystallization screenings
were performed at room temperature using the sitting-drop vapor diffusion
method and 96-well MRC plates (Hampton). Drops consisting of 0.7 μl protein
solution at 5 mgml−1 plus 0.7 μl reservoir solution were equilibrated against 60 μl
of reservoir solution using JCSG+, PACT, and Crystal Screen (Hampton Research)
commercial screens. Diamond and rod-shape crystals appeared after few hours.
Initial hits were further optimized in 24-well sitting-drop plates (Qiagen) using as
reservoir solution 18–22 % PEG 3350, 0.1 M Na2SO4 and 0.1 M Bis-Tris pH 6.5.
The protein freed of UMP was crystallized in 18–22% PEG 3350 and 150–200 mM
potassium acetate. Also, the protein was co-crystallized with 2 mM PALA or
10 mM CP in 25% PEG 3350, 0.2 M Li2SO4, and 0.1 M Bis-Tris pH 5.5. Crystals of
mutant F161A were obtained in similar conditions as the WT protein. All crystals
were cryo-protected in mother liquor supplemented with 20% glycerol and flash-
frozen in liquid nitrogen. X-Ray diffraction data of the APO and +PALA crystals
were collected at beamline MASSIF (ESRF, Grenoble) and the other crystals were
diffracted at beamline BL13-XALOC (ALBA synchrotron, Barcelona) at specific
wavelengths (APO and +PALA, 0.966 Å; +UMP, 0.9793 Å; +PALA+ CP,
0.97924 Å; +CP, 0.97910 Å, F161A+UMP and F161A+ PALA, 0.97926 Å) and at
100 K temperature using Pilatus 6 M detectors (DECTRIS). Data processing and
scaling were performed with XDS55 and autoPROC56. Crystallographic phases
were obtained by molecular replacement using PHASER57 and the structure of the
ATC domain of human CAD (PDB 5G1O)24 as the search model. The models were
constructed by iterative cycles of model building in COOT58 and refinement with
PHENIX59 or Refmac560 in CCP461. Data collection and refinement statistics are
summarized in Supplementary Table 2. In all structures, over 97% residues are in
the favored region of the Ramachandran plot and only the APO and +CP struc-
tures contain, respectively, 0.11% and 0.05% Ramachandran outliers adjacent to
disorder regions. Figures were prepared with PyMOL.
Isothermal titration calorimetry. Experiments were performed in an Auto-
iTC200 calorimeter (MicroCal, Malvern-Panalytical) at 25 °C with a 0.2 ml reaction
cell and 30–40 μM protein solution (in protomer units) in the cell. Titration
experiments consisted of 19 injections of 2 μl of 0.4 mM PALA, 0.4 mM UMP or
1 mM CP. Binding of UMP or CP was also performed on 30–40 μM protein
samples pre-incubated with 80 μM PALA. All solutions were in GF buffer and
degassed and mixed in the cell by stirring at 750 rpm. Data analysis was performed
with Origin 7 (OriginLab) using a general three-site cooperative and a non-
cooperative binding model, restricted to one or two ligand binding sites when
convenient24,62,63. Non-linear least-squares regression analysis was employed to
estimate dissociation constants for the interaction of the different ligands with
ATC. The number of ligand binding sites or stoichiometry was fixed by the model
employed for the analysis (one site, two sites, or three sites); in all experiments the
fraction of active or binding-competent protein was close to 1.
Activity assays. Activity was assayed by a colorimetric method64 adapted to a 96-
well plate format24. The reaction was carried out in 50 mM Tris-acetate (pH 8.3)
and 0.1 mgml−1 BSA in a final volume of 150 μl. atATC was pre-incubated with
Asp for 10 min in a water bath at 25 °C and the reaction was triggered by adding
CP and stopped after 5 min with 100 μl of a color solution consisting of two parts
of reagent A [0.37% (w/v) antipyrine and 0.25% (w/v) ammonium iron(III) sulfate
in 25% (v/v) H2SO4 95% and 25% (v/v) H3PO4 85%] and one part of reagent B
[0.4% (w/v) diacetylmonoxime in 7.5% (w/v) NaCl]. Reagent B is light sensitive and
was stored at 4 °C in the dark. The color reagents were gently mixed and stored at
4 °C in the dark until added to the sample. Reaction tubes were closed, boiled at
95 °C for 15 min, and kept in the dark for 30 min before measuring the absorbance
at 450 nm in a Tecan infinite m200 microplate reader (Tecan). Substrate saturation
curves were done varying the concentration of one substrate maintaining a fix
concentration of the other substrate (5 mM for CP or 10 mM for Asp). Data
analysis was done with GraphPad. In the absence of inhibitors, WT kinetics obey
Michaelis-Menten equation v= [Vmax·X/K0.5+ X], where X is substrate con-
centration and K0.5 is the substrate concentration at which the initial rate (v) is one-
half of the maximum velocity (Vmax)]. In the absence of UMP or PALA, F161A
shows inhibition by excess of substrate and the data was fitted to equation
v= Vmax·X/K0.5+ X(1+ X/Ki), where Ki is the inhibition constant. In the presence
of UMP or PALA, WT kinetics obey the Hill equation [v= Vmax·Xh/K0.5h+ Xh],
whereas F161A kinetics were fitted to a modified equation with the additional term
for substrate inhibition: v= Vmax·Xh/K0.5h+ [Xh(1+ X/Ki)]. Best-fitting values for
the latter equation are ambiguous, since many combinations of these parameters
generate curves that fit the data equally well. Protein concentration in the assay was
0.3 μM (0.01 mgml−1) both for WT and F161A. Inhibition was measured by
adding PALA or UMP during the pre-incubation.
Reporting summary. Further information on research design is available in the Nature
Research Reporting Summary linked to this article.
Data availability
The structural data (coordinates and structure factors) that support the findings of this
study are deposited in the Protein Data Bank (PDB) under accession codes 6YPO
(+UMP), 6YY1 (APO), 6YS6 (+PALA), 6YSP (+PALA+ CP), 6YVB (+ CP), 6YWJ
(F161A+UMP), and 6YW9 (F161A+ PALA). The ITC data that support the findings of
this study are available from the corresponding author upon reasonable request. A
separate source data file contains raw data underlying Figs. 1c–g, 2b, c, 3a, 5a–c, and
Supplementary Figs. 4b, c and 8; it also contains full blots and gels of cropped images
shown in Figs. 1 and 2 (see Supplementary Fig. 9). Source data are provided with
this paper.
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